{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:42:53Z","timestamp":1789717373137,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00280-014-2623-5","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T19:00:51Z","timestamp":1415991651000},"page":"143-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews"],"prefix":"10.1007","volume":"75","author":[{"given":"Julie L.","family":"Eiseman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Rigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Strychor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Dienel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"issue":"Suppl 5","key":"2623_CR1","doi-asserted-by":"crossref","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232\u2013v243","journal-title":"Ann Oncol"},{"issue":"4","key":"2623_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00520-005-0914-4","volume":"14","author":"PJ Hesketh","year":"2006","unstructured":"Hesketh PJ, Grunberg SM, Herrstedt J, de Wit R, Gralla RJ, Carides AD, Taylor A, Evans JK, Horgan KJ (2006) Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response. Support Care Cancer 14(4):354\u2013360","journal-title":"Support Care Cancer"},{"issue":"10","key":"2623_CR3","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2193::AID-CNCR22>3.0.CO;2-T","volume":"78","author":"MG Kris","year":"1996","unstructured":"Kris MG, Cubeddu LX, Gralla RJ, Cupissol D, Tyson LB, Venkatraman E, Homesley HD (1996) Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin. Cancer 78(10):2193\u20132198","journal-title":"Cancer"},{"issue":"Suppl 1","key":"2623_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000227637","volume":"53","author":"M Martin","year":"1996","unstructured":"Martin M (1996) The severity and pattern of emesis following different cytotoxic agents. Oncology 53(Suppl 1):26\u201331","journal-title":"Oncology"},{"issue":"8","key":"2623_CR5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0959-8049(02)00674-3","volume":"39","author":"PJ Hesketh","year":"2003","unstructured":"Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ (2003) Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39(8):1074\u20131080","journal-title":"Eur J Cancer"},{"issue":"32","key":"2623_CR6","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2011.39.5558","volume":"30","author":"C Albany","year":"2012","unstructured":"Albany C, Brames MJ, Fausel C, Johnson CS, Picus J, Einhorn LH (2012) Randomized, double-blind, placebo-controlled, phase iii cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study. J Clin Oncol 30(32):3938\u20134003","journal-title":"J Clin Oncol"},{"key":"2623_CR7","first-page":"15","volume-title":"Management of nausea and vomiting in cancer and cancer treatment","author":"JA Rudd","year":"2005","unstructured":"Rudd JA, Andrews PLR (2005) Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In: Hesketh PJ (ed) Management of nausea and vomiting in cancer and cancer treatment. Jones and Bartlett, Sudbury, pp 15\u201365"},{"issue":"2","key":"2623_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7258(03)00057-3","volume":"99","author":"M Minami","year":"2003","unstructured":"Minami M, Endo T, Hirafuji M, Hamaue N, Liu Y, Hiroshige T, Nemoto M, Saito H, Yoshioka M (2003) Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 99(2):149\u2013165","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2623_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2009.08.075","volume":"465","author":"N Percie du Sert","year":"2009","unstructured":"Percie du Sert N, Rudd JA, Moss R, Andrews PL (2009) The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret. Neurosci Lett 465(1):16\u201320","journal-title":"Neurosci Lett"},{"key":"2623_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00280-010-1339-4","volume":"67","author":"N Percie du Sert","year":"2010","unstructured":"Percie du Sert N, Rudd JA, Apfel CC, Andrews PL (2010) Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT(3) receptor antagonists. Cancer Chemother Pharmacol 67:667\u2013686","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"2623_CR11","first-page":"463","volume":"46","author":"YK Gupta","year":"2002","unstructured":"Gupta YK, Sharma SS (2002) Involvement of 5-HT1A and 5-HT2 receptor in cisplatin induced emesis in dogs. Indian J Physiol Pharmacol 46(4):463\u2013467","journal-title":"Indian J Physiol Pharmacol"},{"issue":"1\u20132","key":"2623_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(03)01863-6","volume":"472","author":"TS Sam","year":"2003","unstructured":"Sam TS, Cheng JT, Johnston KD, Kan KK, Ngan MP, Rudd JA, Wai MK, Yeung JH (2003) Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol 472(1\u20132):135\u2013145","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2623_CR13","doi-asserted-by":"crossref","first-page":"R902","DOI":"10.1152\/ajpregu.90952.2008","volume":"296","author":"BC Jonghe De","year":"2009","unstructured":"De Jonghe BC, Horn CC (2009) Chemotherapy agent cisplatin induces 48\u00a0h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus). Am J Physiol Regul Integr Comp Physiol 296(4):R902\u2013R911","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2623_CR14","first-page":"88","volume":"5","author":"CC Horn","year":"2011","unstructured":"Horn CC, Henry S, Meyers K, Magnusson MS (2011) Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews. Front Neurosci 5:88","journal-title":"Front Neurosci"},{"issue":"2","key":"2623_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneumeth.2011.02.032","volume":"197","author":"D Huang","year":"2011","unstructured":"Huang D, Meyers K, Henry S, De la Torre F, Horn CC (2011) Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew. J Neurosci Methods 197(2):249\u2013258","journal-title":"J Neurosci Methods"},{"issue":"7","key":"2623_CR16","first-page":"2803","volume":"29","author":"AG Zeimet","year":"2009","unstructured":"Zeimet AG, Reimer D, Radl AC, Reinthaller A, Schauer C, Petru E, Concin N, Braun S, Marth C (2009) Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer. Anticancer Res 29(7):2803\u20132808","journal-title":"Anticancer Res"},{"key":"2623_CR17","volume-title":"Tachykinins. Handbook of experimental pharmacology","author":"P Holzer","year":"2004","unstructured":"Holzer P (2004) Tachykinins. Handbook of experimental pharmacology, vol 164. Springer, Berlin"},{"issue":"4","key":"2623_CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12272-009-1413-9","volume":"32","author":"QH Qian","year":"2009","unstructured":"Qian QH, Yue W, Wang YX, Yang ZH, Liu ZT, Chen WH (2009) Gingerol inhibits cisplatin-induced vomiting by down regulating 5-hydroxytryptamine, dopamine and substance P expression in minks. Arch Pharm Res 32(4):565\u2013573","journal-title":"Arch Pharm Res"},{"issue":"2","key":"2623_CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334(2):115\u2013124","journal-title":"Am J Med Sci"},{"key":"2623_CR20","unstructured":"Wang CH (1994) Introduction: a new experimental animal, Suncus murinus. In: Saito H, Wang CH, Chen CY (eds) Proceeding of ROC-Japan Symposium on Suncus murinus: new experimental animal, its speciality and usefulness, Tainan, Taiwan, R.O.C. Chia Nan Junior College of Pharmacy Press (Chia Nan, Taiwan ROC)"},{"issue":"1","key":"2623_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ilar.45.1.25","volume":"45","author":"JL Temple","year":"2004","unstructured":"Temple JL (2004) The musk shrew (Suncus murinus): a model species for studies of nutritional regulation of reproduction. ILAR J 45(1):25\u201334","journal-title":"ILAR J"},{"issue":"1","key":"2623_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1051\/ject\/201042075","volume":"42","author":"H Colville","year":"2010","unstructured":"Colville H, Dzadony R, Kemp R, Stewart S, Zeh HJ 3rd, Bartlett DL, Holleran J, Schombert K, Kosovec JE, Egorin MJ, Beumer JH (2010) In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion. J Extra Corpor Technol 42(1):75\u201379","journal-title":"J Extra Corpor Technol"},{"issue":"1","key":"2623_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0196-9781(86)90076-8","volume":"7","author":"RE Watson Jr","year":"1986","unstructured":"Watson RE Jr, Wiegand SJ, Clough RW, Hoffman GE (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7(1):155\u2013159","journal-title":"Peptides"},{"issue":"3","key":"2623_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cne.901960312","volume":"196","author":"DM Armstrong","year":"1981","unstructured":"Armstrong DM, Pickel VM, Joh TH, Reis DJ, Miller RJ (1981) Immunocytochemical localization of catecholamine synthesizing enzymes and neuropeptides in area postrema and medial nucleus tractus solitarius of rat brain. J Comp Neurol 196(3):505\u2013517","journal-title":"J Comp Neurol"},{"issue":"7","key":"2623_CR25","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.74.7.3081","volume":"74","author":"T Hokfelt","year":"1977","unstructured":"Hokfelt T, Ljungdahl A, Terenius L, Elde R, Nilsson G (1977) Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc Natl Acad Sci USA 74(7):3081\u20133085","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2623_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/exnr.1996.0050","volume":"138","author":"I Barajon","year":"1996","unstructured":"Barajon I, Bersani M, Quartu M, Del Fiacco M, Cavaletti G, Holst JJ, Tredici G (1996) Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol 138(1):93\u2013104","journal-title":"Exp Neurol"},{"issue":"3","key":"2623_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661","journal-title":"FASEB J"},{"issue":"4","key":"2623_CR28","doi-asserted-by":"crossref","first-page":"e60537","DOI":"10.1371\/journal.pone.0060537","volume":"8","author":"CC Horn","year":"2013","unstructured":"Horn CC, Kimball BA, Wang H, Kaus J, Dienel S, Nagy A, Gathright GR, Yates BJ, Andrews PLR (2013) Why can\u2019t rodents vomit? A comparative behavioral, anatomical, and physiological study. PLoS ONE 8(4):e60537","journal-title":"PLoS ONE"},{"issue":"8","key":"2623_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.2042-7158.1997.tb06111.x","volume":"49","author":"M Nakashima","year":"1997","unstructured":"Nakashima M, Shibata S, Tokunaga Y, Fujita H, Anda T, Arizono K, Tomiyama N, Sasaki H, Ichikawa M (1997) In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma. J Pharm Pharmacol 49(8):777\u2013780","journal-title":"J Pharm Pharmacol"},{"key":"2623_CR30","unstructured":"Brown R, Foran J, Olin S, Robinson D (1994) Physiological parameter values for PBPK models. International Life Sciences Institute: Risk Science Institute, Washington, DC"},{"issue":"5","key":"2623_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00016480701635167","volume":"128","author":"R Ramirez-Camacho","year":"2008","unstructured":"Ramirez-Camacho R, Fernandez DE, Verdaguer JM, Gomez MM, Trinidad A, Garcia-Berrocal JR, Corvillo MA (2008) Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration. Acta Otolaryngol 128(5):505\u2013509","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"2623_CR32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jat\/32.2.140","volume":"32","author":"D Esteban-Fernandez","year":"2008","unstructured":"Esteban-Fernandez D, Verdaguer JM, Ramirez-Camacho R, Palacios MA, Gomez-Gomez MM (2008) Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol 32(2):140\u2013146","journal-title":"J Anal Toxicol"},{"issue":"1\u20132","key":"2623_CR33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00685625","volume":"37","author":"A Johnsson","year":"1995","unstructured":"Johnsson A, Olsson C, Nygren O, Nilsson M, Seiving B, Cavallin-Stahl E (1995) Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts. Cancer Chemother Pharmacol 37(1\u20132):23\u201331","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2623_CR34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/ijms.8.487","volume":"8","author":"T Sakaeda","year":"2011","unstructured":"Sakaeda T, Kadoyama K, Okuno Y (2011) Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations. Int J Med Sci 8(6):487\u2013491","journal-title":"Int J Med Sci"},{"issue":"3","key":"2623_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2982.1996.tb00265.x","volume":"8","author":"FM Boissonade","year":"1996","unstructured":"Boissonade FM, Davison JS, Egizii R, Lucier GE, Sharkey KA (1996) The dorsal vagal complex of the ferret: anatomical and immunohistochemical studies. Neurogastroenterol Motil 8(3):255\u2013272","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"2623_CR36","first-page":"397","volume":"44","author":"DD Choie","year":"1981","unstructured":"Choie DD, Longnecker DS, del Campo AA (1981) Acute and chronic cisplatin nephropathy in rats. Lab Invest 44(5):397\u2013402","journal-title":"Lab Invest"},{"issue":"3","key":"2623_CR37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2005010102","volume":"17","author":"M Liu","year":"2006","unstructured":"Liu M, Chien CC, Burne-Taney M, Molls RR, Racusen LC, Colvin RB, Rabb H (2006) A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol 17(3):765\u2013774","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"2623_CR38","first-page":"6297","volume":"47","author":"MB Hennik van","year":"1987","unstructured":"van Hennik MB, van der Vijgh WJ, Klein I, Elferink F, Vermorken JB, Winograd B, Pinedo HM (1987) Comparative pharmacokinetics of cisplatin and three analogues in mice and humans. Cancer Res 47(23):6297\u20136301","journal-title":"Cancer Res"},{"issue":"9","key":"2623_CR39","first-page":"2992","volume":"8","author":"WC Zamboni","year":"2002","unstructured":"Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL (2002) Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin. Clin Cancer Res 8(9):2992\u20132999","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2623_CR40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00685038","volume":"31","author":"R Kizu","year":"1993","unstructured":"Kizu R, Higashi S, Kidani Y, Miyazaki M (1993) Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits. Cancer Chemother Pharmacol 31(6):475\u2013480","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"2623_CR41","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2460\/ajvr.1991.52.11.1821","volume":"52","author":"EM Hardie","year":"1991","unstructured":"Hardie EM, Page RL, Williams PL, Fischer WD (1991) Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs. Am J Vet Res 52(11):1821\u20131825","journal-title":"Am J Vet Res"},{"issue":"4","key":"2623_CR42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1078-0432.CCR-04-1807","volume":"11","author":"SS Jacobs","year":"2005","unstructured":"Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM (2005) Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 11(4):1669\u20131674","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2623_CR43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2125.2004.02082.x","volume":"57","author":"S Urien","year":"2004","unstructured":"Urien S, Lokiec F (2004) Population pharmacokinetics of total and unbound plasma cisplatin in adult patients. Br J Clin Pharmacol 57(6):756\u2013763","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2623_CR44","first-page":"219","volume":"50","author":"EJ Freireich","year":"1966","unstructured":"Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep Part 1 50(4):219\u2013244","journal-title":"Cancer Chemother Rep Part 1"},{"issue":"1","key":"2623_CR45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00319454","volume":"170","author":"Y Sugiura","year":"1984","unstructured":"Sugiura Y, Kitoh J (1984) The median and lateral substantia gelatinosa in the cervical cord of the musk shrew (Suncus murinus) and its synaptic composition. Anat Embryol (Berl) 170(1):21\u201328","journal-title":"Anat Embryol (Berl)"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2623-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2623-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T01:14:55Z","timestamp":1717550095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2623"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2623-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}